Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;8(Suppl 5):S479-S492.
doi: 10.21037/tcr.2019.05.12.

Rare epithelial breast cancer: surgery and adjuvant therapy

Aida Abdelwahed  1 , Muneer Ahmed  2
Affiliations
Review

Rare epithelial breast cancer: surgery and adjuvant therapy

Aida Abdelwahed et al. Transl Cancer Res. 2019 Oct.

Abstract

Breast cancer is a heterogenous disease, exhibiting a wide range of morphological phenotypes shaping its prognosis and clinical course. However, optimal management of rarer breast cancer subtypes is often undefined and controversial in literature due to the lack of large studies and randomised trials. This review aims to discuss the treatment of 13 rare epithelial subtypes, focussing on surgery and adjuvant therapies.

Keywords: Epithelial breast cancer; adjuvant therapy; optimal management; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.05.12). The focused issue “Rare Tumors of the Breast” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

References

    1. Yerushalmi R, Hayes MM, Gelmon KA. Breast carcinoma--rare types: review of the literature. Ann Oncol 2009;20:1763-70. 10.1093/annonc/mdp245 - DOI - PubMed
    1. Acevedo C, Amaya C, Lopez-Guerra JL. Rare breast tumors: Review of the literature. Rep Pract Oncol Radiother 2014;19:267-74. 10.1016/j.rpor.2013.08.006 - DOI - PMC - PubMed
    1. Lea V, Gluch L, Kennedy CW, et al. Tubular carcinoma of the breast: axillary involvement and prognostic factors. ANZ J Surg 2015;85:448-51. 10.1111/ans.12791 - DOI - PubMed
    1. Anan K, Mitsuyama S, Tamae K, et al. Tubular carcinoma of the breast: a histologic subtype indicative of breast-conserving therapy. Surg Today 2000;30:1057-61. 10.1007/s005950070001 - DOI - PubMed
    1. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113-8. 10.1200/JCO.1990.8.1.113 - DOI - PubMed